Insud’s mAbxience Inaugurates New Biosimilar Plant Facility in Argentina

 Insud’s mAbxience Inaugurates New Biosimilar Plant Facility in Argentina

10. Insud’s mAbxience Inaugurates New Biosimilar Plant Facility in Argentina

  • The development project involves investment of $40M and doubled its production capacity and will export biosimilar in Central America, South America, Africa, Asia and the Middle East
  • The plant will currently have 162 employees with 50 new jobs, and it is expected to generate another 50 positions over the coming years work according to GMP
  • The company will own now three biosimilar plants two in Argentina and one in Spain (León)

Click here to read full press release/ article | Ref: mAbxience | Image: Twitter

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post